LAI
RMD icon

Legal Advantage Investments’s ResMed RMD Stock Holding History

Legal Advantage Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,400
Closed -$708K – 94
2022
Q4 		$708K Sell
3,400
-50
-1% -$11K 0.58% 48
2022
Q3 		$753K Hold
3,450
– – 0.71% 42
2022
Q2 		$723K Hold
3,450
– – 0.7% 40
2022
Q1 		$837K Sell
3,450
-150
-4% -$36.3K 0.63% 48
2021
Q4 		$937K Buy
+3,600
New +$934K 0.64% 45
2021
Q1 		– Sell
-3,000
Closed -$638K – 92
2020
Q4 		$638K Buy
+3,000
New +$598K 0.5% 52

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal Advantage Investments's RMD Position: Q1 2023 in Review

Legal Advantage Investments sold out of ResMed (RMD) in Q1 2023, closing a stake of 3,400 shares — an estimated $708K sold.

Legal Advantage Investments first reported a position in RMD in Q4 2020 and held it in 6 quarters. The position peaked at $937K in Q4 2021. 677 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

  • Legal Advantage Investments reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
  • Legal Advantage Investments sold 3,400 ResMed shares in Q1 2023, an estimated $708K.
  • Legal Advantage Investments first reported a position in ResMed in Q4 2020 and held it in 6 quarters.
  • Legal Advantage Investments's ResMed position peaked at $937K in Q4 2021.
  • 677 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Legal Advantage Investments's 13F filing for Q1 2023, filed 24 Apr 2023.